Unicycive Therapeutics Inc. (UNCY)

Trial Meets Milestone With Complete Enrollment


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
March 11, 2024
Report ID: 26586
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc.
Healthcare
Biotechnology
Ticker
UNCY
Current Price
$1.1 -3.51%
Market Cap
$38.2M
Price Target
Refer to Report
Volume
397.1K
52wk Range
$0.47 - $1.83
Related Research Reports
3/11/2024

Trial Meets Milestone With Complete Enrollment
Trial Meets Milestone With Complete Enrollment (UNCY)
2/14/2024

Initiating Coverage With An Outperform Rating
Initiating Coverage With An Outperform Rating (UNCY)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.